Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Toxic epidermal necrolysis with severe hyperbilirubinemia: complete re-epithelialization after bilirubin reduction therapies.

Kamada N, Yoneyama K, Togawa Y, Suehiro K, Shinkai H, Yokota M, Matsuda K, Oda S, Hirasawa H, Matsue H.

J Dermatol. 2010 Jun;37(6):534-6. doi: 10.1111/j.1346-8138.2009.00770.x.

PMID:
20536667
2.

Absence of re-epithelialization in a fatal case of toxic epidermal necrolysis: is hyperbilirubinemia a culprit?

Kamada N, Utani A, Yoneyama K, Kobayashi T, Momota Y, Matsumoto F, Nakada T, Hirasawa H, Shinkai H.

Arch Dermatol. 2005 Jan;141(1):107-9. No abstract available.

PMID:
15655162
3.

Toxic epidermal necrolysis (Lyell syndrome).

Roujeau JC, Chosidow O, Saiag P, Guillaume JC.

J Am Acad Dermatol. 1990 Dec;23(6 Pt 1):1039-58. Review.

PMID:
2273103
4.

Toxic epidermal necrolysis in a child after carbamazepine dosage increment.

Sevketoglu E, Hatipoglu S, Akman M, Bicer S.

Pediatr Emerg Care. 2009 Feb;25(2):93-5. doi: 10.1097/PEC.0b013e318196eac4.

PMID:
19225374
5.

Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.

Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau JC, Bagot M.

Arch Dermatol. 1995 May;131(5):544-51.

PMID:
7741540
6.

Hypopharyngeal stenosis and dysphagia complicating toxic epidermal necrolysis.

Barrera JE, Meyers AD, Hartford EC.

Arch Otolaryngol Head Neck Surg. 1998 Dec;124(12):1375-6.

PMID:
9865761
7.

Toxic epidermal necrolysis associated with quinidine administration.

Adornato MC.

N Y State Dent J. 2000 Mar;66(3):38-40.

PMID:
10808726
9.

[Drug-induced toxic epidermal necrolysis with involvement of the intestinal and respiratory tract. A case report].

Jäckel R, Fuchs M, Raff T, Wiedemann B.

Anaesthesist. 2002 Oct;51(10):815-9. German.

PMID:
12395172
10.

Beneficial therapeutic effect of plasmapheresis after unsuccessful treatment with corticosteroids in two patients with severe toxic epidermal necrolysis.

Szczeklik W, Nowak I, Seczynska B, Sega A, Krolikowski W, Musial J.

Ther Apher Dial. 2010 Jun;14(3):354-7. doi: 10.1111/j.1744-9987.2009.00800.x.

PMID:
20609191
11.

Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis?

Furubacke A, Berlin G, Anderson C, Sjöberg F.

Intensive Care Med. 1999 Nov;25(11):1307-10.

PMID:
10654219
12.

Toxic epidermal necrolysis: a burn-centre challenge.

Peters W, Zaidi J, Douglas L.

CMAJ. 1991 Jun 1;144(11):1477-80.

13.
14.

Anesthetic management of toxic epidermal necrolysis: report of three adult cases.

Rabito SF, Sultana S, Konefal TS, Candido KD.

J Clin Anesth. 2001 Mar;13(2):133-7.

PMID:
11331176
15.

Bilirubin adsorbent column for plasma perfusion.

Takenaka Y.

Ther Apher. 1998 May;2(2):129-33. Review.

PMID:
10225714
16.

[Toxic epidermal necrolysis associated to the use of valproic acid].

Guevara-Campos J, González-De Guevara L, Berardi-Lorenzón ML, Ibrahim G, Mejías P, Agelvis MC.

Rev Neurol. 2010 Apr 1;50(7):444-5. Spanish. No abstract available.

17.

Toxic epidermal necrolysis caused by flurazepam?

Loncar C, Franić T, Bilusić M.

Psychiatr Danub. 2005 Dec;17(3-4):236-9.

PMID:
16392434
18.

[Toxic epidermal necrolysis due to lamotrigine].

Beerhorst K, Renier WO.

Ned Tijdschr Geneeskd. 2003 Jun 7;147(23):1128-31. Dutch.

PMID:
12822524
19.

Plasma exchange in patients with toxic epidermal necrolysis.

Bamichas G, Natse T, Christidou F, Stangou M, Karagianni A, Koukourikos S, Chaidemenos G, Chrysomallis F, Sombolos K.

Ther Apher. 2002 Jun;6(3):225-8.

PMID:
12109948
20.

Survival after a second episode of toxic epidermal necrolysis.

Dreyfuss DA, Gottlieb LJ, Wilkerson DK, Parsons RW, Krizek TJ.

Ann Plast Surg. 1988 Feb;20(2):146-7.

PMID:
3355061

Supplemental Content

Support Center